510(k) K903531

ANTICARDIOLIPIN ANTIBODY TEST SYSTEM by Medical Innovations Corp. — Product Code GFO

K903531 is an FDA 510(k) premarket notification submitted by Medical Innovations Corp. for the device "ANTICARDIOLIPIN ANTIBODY TEST SYSTEM". The FDA issued a decision of Substantially Equivalent on Jan 25, 1991. The device falls under product code GFO (Activated Partial Thromboplastin), a Class II device regulated under 21 CFR 864.7925. Medical Innovations Corp. has 23 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jan 25, 1991
Date Received
Aug 6, 1990
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Activated Partial Thromboplastin
Device Class
Class II
Regulation Number
864.7925
Review Panel
HE
Submission Type
510(k)

Need the full FDA record for Medical Innovations Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K903531. Report a data issue: hello@regdatalab.com.